Project Overview: Athenex is a global oncology focused biopharmaceutical company focused on the development and commercialization of next generation therapies for cancer diseases and supportive therapies. The company was founded in 2003 in Buffalo, NY. Athenex used $200 million of New York State funding to create a 320,000-square-foot High Pharmacy Oncology Manufacturing Facility in Dunkirk, NY.
Stark Involvement: U&S Services provided the integration solution for the Building Management System, Plant Control System, and Energy Management System for the new facility in Dunkirk. Stark’s Equipment division provided the Boilers for the new building as well.